250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology VC (Venture Capital) Funds in Austria in May 2025

A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in Austria. We rank investors based on the number of investments they made in Biotechnology companies from Austria. We update this investor list every month.

Top 50 Biotechnology VC (Venture Capital) Funds in Austria in May 2025

Investor Biotechnology Austria investments
xista science ventures 10
xista science ventures 9
tecnet equity 6
MIG Capital 5
SOSV 5
austria Wirtschaftsservice (aws) 5
Arax Capital Partners 3
TSVC 2
aws Gründungsfonds 2
Aescap Venture 2
10x Founders 2
The Austrian Research Promotion Agency (FFG) 2
APEX Ventures 2
Nina Capital 2
Übermorgen Ventures 2
bmp Ventures 2
PUSH VC 2
APEX Ventures 2
R42 Group 2
Longevitytech.fund 2
FPS-Holding 2
Lansdowne Partners 2
red-stars.com 2
BackBone Ventures 2
Synthesis Capital 1
Forbion Capital Partners 1
Pace Ventures 1
Possible Ventures 1
HBM Partners 1
4SC 1
Climentum Capital 1
Techno Venture Management 1
Air Street Capital 1
Andera Partners 1
42CAP 1
NovaCapital 1
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H 1
PONTIS Venture Partners Management 1
Ligand Pharmaceuticals 1
Fund F 1
Clima Now 1
Kale United 1
Polaris Partners 1
ReGen Ventures 1
Auxxo 1
Satgana 1
Borregaard ASA 1
Die Wirtschaftskammer 1
Axilium Holding 1
GLS Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
xista science ventures VC Fund · Klosterneuburg, Niederosterreich, Austria
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
  • Biotechnology, Medical, Medical Device
  • Seed, Pre-Seed, Series A
  • Austria, France, Slovenia
Portfolio highlights
  • Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
  • HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
xista science ventures VC Fund · Klosterneuburg, Niederosterreich, Austria
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
  • Biotechnology, Medical, Software
  • Seed, Pre-Seed, Series A
  • Austria, Slovenia
Portfolio highlights
  • subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
tecnet equity VC Fund · Sankt Polten, Niederosterreich, Austria
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Funding Round, Series A
  • Austria
Portfolio highlights
  • Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
  • Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
  • VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
MIG Capital VC Fund · München, Bayern, Germany · 2 investments in the past 12 months
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Germany, France, Austria
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
austria Wirtschaftsservice (aws) VC Fund · Vienna, Wien, Austria
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Grant, Pre-Seed
  • Austria, Belgium
Portfolio highlights
  • HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
  • Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
  • Aileen Health — Next frame predictions for medical images.
Arax Capital Partners VC Fund · Vienna, Wien, Austria
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round
  • Austria
Portfolio highlights
  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
  • Calyxha Biotechnologies GmbH — A new perspective on inflammation
TSVC VC Fund · Los Altos, California, United States · 2 investments in the past 12 months
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Seed, Funding Round, Series A
  • United States, China, Canada
Portfolio highlights
  • Akool — Akool provides a generative AI platform that supercharges business with personalized premium quality visual content for marketing and advertisement.
  • Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
  • Place Genomics Corporation — Bio Tech
aws Gründungsfonds VC Fund · Vienna, Wien, Austria · 3 investments in the past 12 months
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • Austria, United States, Germany
Portfolio highlights
  • Tree.ly — Tree.ly does climate protection through the projects in European forests through its SaaS platform and hyperlocal CO2-credits.
  • Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
  • HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Aescap Venture VC Fund · Amsterdam, Noord-Holland, The Netherlands
The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Chemical
  • Series A, Series B, Funding Round
  • United Kingdom, Austria, Belgium
Portfolio highlights
  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
10x Founders VC Fund · Munich, Bayern, Germany · 13 investments in the past 12 months
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • Germany, United States, United Kingdom
Portfolio highlights
  • Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
  • Landeed — Do you own your land? Download Landeed app to check real ownership of your property
  • qeen.ai — qeen.ai is a GenAI native platform that enables autonomous AI to e-commerce firms of all sizes.
The Austrian Research Promotion Agency (FFG) VC Fund · Vienna, Wien, Austria · 10 investments in the past 12 months
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Grant, Seed, Pre-Seed
  • Austria, United States, Belgium
Portfolio highlights
  • Synaps — The collaborative architectural platform where you can draw plans, delegate tasks and gather real-time feedback, all in one place. Join the waitlist.
  • SOMAREALITY — SOMAREALITY provides eye tracking solutions for diverse industries. Improve healthcare, automotive, research & aviation with real-time cognitive insights.
  • Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
APEX Ventures VC Fund · Vienna, Wien, Austria · 6 investments in the past 12 months
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 10 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Germany
Portfolio highlights
  • CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
  • Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
  • MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
Übermorgen Ventures VC Fund · Zürich, Zurich, Switzerland · 3 investments in the past 12 months
We are an early stage VC for climate tech startups.
Show more
Investment focus
  • Software, Energy, Renewable Energy
  • Seed, Pre-Seed, Funding Round
  • Germany, Switzerland, Finland
Portfolio highlights
  • Green Fusion — Green Fusion is developing a cloud-based energy manager for the intelligent control of heat, electricity, and e-mobility. The focus here is on hybrid heating systems in buildings such as heat pumps + gas boilers and the coupling to photovoltaic systems and electric vehicle charging stations.
  • Marathon Fusion — The fuel cycle for fusion energy.
  • Open Forest Protocol — With Open Forest Protocol (OFP), measure, report, verify and fund forestation projects with digital transparency
bmp Ventures VC Fund · Berlin, Berlin, Germany · 2 investments in the past 12 months
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
  • Information Technology, Software, Manufacturing
  • Seed, Funding Round, Series A
  • Germany, United States, Austria
Portfolio highlights
  • Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
  • RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
  • XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.
PUSH VC VC Fund · Vienna, Wien, Austria · 2 investments in the past 12 months
| Investments that move industries
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Austria, Germany, United States
Portfolio highlights
  • Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
  • enspired — enspired is a fully digital energy trading-as-a-service company. We drive the energy transition by enabling our clients to bring flexible assets to power spot markets and capture their full value with our AI-based trading services. Our team consists of leading algorithmic traders, data scientists and technology enthusiasts who firmly believe thatthe way power is traded will soon drastically change - in our world, there is no room for trading screens and traditional optimization. All trades get executed in a fully automated fashion using advanced AI algorithms that outperform the market and monetize our client's flexibility to the fullest while supporting grid stability. Our clients include leading utilities, operators of renewables and batteries or consumption assets across Europe.
  • UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
APEX Ventures VC Fund · Vienna, Wien, Austria · 4 investments in the past 12 months
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
R42 Group VC Fund · Stanford, California, United States · 2 investments in the past 12 months
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
  • Biotechnology, Health Care, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United Kingdom, United States, Austria
Portfolio highlights
  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Longevitytech.fund VC Fund · Prague, Hlavni mesto Praha, Czech Republic
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
  • Biotechnology, Health Care, Personal Health
  • Seed, Convertible Note, Pre-Seed
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
FPS-Holding VC Fund · 2 investments in the past 12 months
SPV
Show more
Investment focus
  • Biotechnology, Health Diagnostics
  • Seed
  • Austria
Portfolio highlights
  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Lansdowne Partners VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Fundamental Equity Investing, since 1998
Show more
Investment focus
  • Biotechnology, Machine Learning, Finance
  • Funding Round, Series A, Series B
  • United Kingdom, Austria, United States
Portfolio highlights
  • Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
  • AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
red-stars.com VC Fund
red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.
Show more
Investment focus
  • Software, Biotechnology, Telecommunications
  • Funding Round, Seed
  • Austria, Germany
Portfolio highlights
  • Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
  • a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
BackBone Ventures VC Fund · Zurich, Zurich, Switzerland · 7 investments in the past 12 months
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more
Investment focus
  • Information Technology, Artificial Intelligence, Software
  • Seed, Pre-Seed, Funding Round
  • Switzerland, Germany, Israel
Portfolio highlights
  • Syn2core — We are a startup in stealth mode, working on an AI co-pilot to empower frontline workers in automotive.
  • Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
  • CROWN — Drive savings and supplier competition with CROWN's eAuction service. Smart reverse auctions built for procurement teams. Book your free demo today.
Synthesis Capital VC Fund · London, England, United Kingdom
We are The Future Food Investors. Alternative Proteins Pioneers, we combine Smart Capital, Deep Expertise and Food Tech Startups!
Show more
Investment focus
  • Biotechnology, Food and Beverage, Organic Food
  • Seed, Funding Round, Series A
  • United States, Israel, Austria
Portfolio highlights
  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Hyfé — Hyfé Foods is a biotech company producing ingredients by leveraging fungal fermentation to upcycle water byproducts from food manufacturers.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 11 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Aiolos Bio — Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by anaccomplished team with decades of drug development experience and leadership in the biotech industry.
  • Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
Pace Ventures VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
Investing at the intersection of climate and health.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United States, Germany, Austria
Portfolio highlights
  • Turnover Labs — Turnover Labs strives to decarbonize the chemical production business and transform how the world generates petrochemicals.
  • Vema Hydrogen — Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.
  • Dunia Innovation — Catalysing the energy transition.
Possible Ventures VC Fund · Munich, Bayern, Germany · 7 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
  • Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
HBM Partners VC Fund · Zug, Zug, Switzerland
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series B, Funding Round, Series C
  • United States, Germany, Switzerland
Portfolio highlights
  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
  • Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
4SC VC Fund · Planegg, Bayern, Germany
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Show more
Investment focus
  • Health Care, Biotechnology
  • Seed
  • Austria
Portfolio highlights
  • Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Climentum Capital VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in the past 12 months
A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions
Show more
Investment focus
  • CleanTech, Clean Energy, Biotechnology
  • Seed, Series A, Series B
  • Sweden, Spain, Austria
Portfolio highlights
  • ecoLocked — ecoLocked is your partner to create a climate-positive built environment. We develop CO2-optimized recipes for concrete based on carbon-negative biochar admixes. Our admixes allow to store captured CO2 in buildings, reduce direct emissions from concrete production, and provide multiple functional benefits, such as improved thermal insulation.
  • Scale Energy — Reduce your energy cost without any investment
  • ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
Techno Venture Management VC Fund · Boston, Massachusetts, United States
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Series B, Series A
  • United States, Germany, United Kingdom
Portfolio highlights
  • Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
  • Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
  • Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
Air Street Capital VC Fund · London, England, United Kingdom · 3 investments in the past 12 months
Air Street Capital invests in AI-first companies.
Show more
Investment focus
  • Artificial Intelligence, Machine Learning, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Sereact — Discover the world's easiest pick and place automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
  • Fern Labs — Deploying agents at the scale of real world problems
  • Odyssey — We're pioneering world models, the next frontier of artificial intelligence.
Andera Partners VC Fund · Paris, Ile-de-France, France · 14 investments in the past 12 months
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Private Equity, Funding Round
  • France, United States, Germany
Portfolio highlights
  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
42CAP VC Fund · Munich, Bayern, Germany · 5 investments in the past 12 months
We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Series B
  • Germany, France, Sweden
Portfolio highlights
  • Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
  • cognee inc — cognee helps you create a GraphRAG and supports Vector Stores, Graph stores, and various LLM providers
  • simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage
NovaCapital VC Fund · Milano, Lombardia, Italy · 2 investments in the past 12 months
NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Series A
  • Italy, Austria
Portfolio highlights
  • Ekore — Miglioriamo la gestione degli edifici ottimizzando i consumi e la gestione delle manutenzioni tramite il concetto di Digital Twin.
  • ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
  • BeDimensional — New Material Solution
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H VC Fund · Graz, Steiermark, Austria
Financing for startups in Styria
Show more
Investment focus
  • Software, Audio, Travel
  • Seed, Grant, Funding Round
  • Austria
Portfolio highlights
  • teamazing — Unlock your team's full potential! Tailored workshops, tools & events for continuous team development. Analyze, build, and grow with teamazing!
  • Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
  • Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.
PONTIS Venture Partners Management VC Fund · Vienna, Wien, Austria
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Series A, Series B, Series C
  • Austria, Germany
Portfolio highlights
  • evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
  • SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
  • EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Ligand Pharmaceuticals VC Fund · San Diego, California, United States · 3 investments in the past 12 months
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Corporate Round, Post-IPO Debt, Series A
  • United States, Austria
Portfolio highlights
  • Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
  • invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.
  • Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Fund F VC Fund · 4 investments in the past 12 months
The European Venture Fund that backs gender-diverse founder teams.
Show more
Investment focus
  • AgTech, EdTech, Software
  • Pre-Seed, Seed
  • Austria, United Kingdom
Portfolio highlights
  • Senvo — Centralized last mile data analytics for optimization, automation, and financial transparency.
  • KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
  • Willow Stories — Preserve your legacy and honor loved ones by creating lasting memorials.
Clima Now VC Fund · Zürich, Zurich, Switzerland
Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.
Show more
Investment focus
  • Farming, Renewable Energy, Solar
  • Seed, Grant, Pre-Seed
  • Switzerland, Germany, Austria
Portfolio highlights
  • Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
  • Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
  • Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen
Kale United VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in the past 12 months
Kale United offers a portfolio of over 75+ plant-based game changers
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, Sweden, India
Portfolio highlights
  • Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
  • The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
  • Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
Polaris Partners VC Fund · Boston, Massachusetts, United States · 16 investments in the past 12 months
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Singapore, Ireland
Portfolio highlights
  • Tausight — Tausight is specifically designed to help Healthcare ensure the confidentiality, integrity, and availability of ePHI.
  • Triveni Bio — Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.
  • Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.
ReGen Ventures VC Fund · Byron Bay, New South Wales, Australia · 5 investments in the past 12 months
Investing in the ReGeneration
Show more
Investment focus
  • Agriculture, Biotechnology, Farming
  • Seed, Series A, Series B
  • United States, Austria, United Kingdom
Portfolio highlights
  • Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
  • PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
  • Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.
Auxxo VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months
The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female (co-)founded startups in Europe.
Show more
Investment focus
  • Software, Health Care, FinTech
  • Seed, Pre-Seed, Series A
  • Germany, United Kingdom, France
Portfolio highlights
  • BIOVOX — Mit Biokunststoff aus nachwachsenden Rohstoffen bis zu 85% CO2 einsparen. Hergestellt unter ISO 13485, biokompatibel nach ISO 10993.
  • Recyda GmbH — All-in-one Packaging Recyclability Management
  • Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.
Satgana VC Fund · Luxembourg, Luxembourg, Luxembourg · 5 investments in the past 12 months
Satgana is a Climate Tech VC firm on a mission to invest in planet-positive startups building the Future of Earth.
Show more
Investment focus
  • Electronics, B2B, Biotechnology
  • Pre-Seed, Seed
  • Kenya, France, Austria
Portfolio highlights
  • Wattnow — Wattnow is a real-time monitoring solution that provides a breakdown of energy spending to identify wasteful trends.
  • NitroVolt — NitroVolt: the next generational step of sustainable ammonia.
  • Brineworks — Brineworks is making sustainble CO2 and H2 production afforable. The building blocks for green fuels - from seawater.
Borregaard ASA VC Fund · Sarpsborg, Ostfold, Norway
Borregaard operates one of the world's most advanced and sustainable biorefineries.
Show more
Investment focus
  • Biotechnology, Chemical Engineering
  • Seed
  • Austria
Portfolio highlights
  • Kaffe Bueno — Kaffe Bueno upcycles coffee waste into active and functional ingredients for cosmetics, nutraceuticals and functional foods.
  • Alginor ASA — Alginor ASA is a marine biotech company committed to total utilisation of kelp through novel methods, making more than just alginates.
  • Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.
Die Wirtschaftskammer VC Fund · Vienna, Wien, Austria
The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.
Show more
Investment focus
  • Software, Music, mHealth
  • Seed, Pre-Seed, Funding Round
  • Austria
Portfolio highlights
  • Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
  • The Apollinaire Group (TAG) — Intelligent supply chain management company.
  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Axilium Holding VC Fund
Axilium Holding
Show more
Investment focus
  • Life Science, Biotechnology, Semiconductor
  • Seed
  • Austria
Portfolio highlights
  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
GLS Ventures VC Fund · Sugar Land, Texas, United States
GLS Ventures
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series B, Funding Round
  • Austria
Portfolio highlights
  • Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Austria by industry